Euryjanicin A

General Information


DRACP ID  DRACP04219

Peptide Name   Euryjanicin A

Sequence  WPISFVP

Sequence Length  7

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiviral; Antiparasitic



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C44H60N8O9

Absent amino acids  ACDEGHKLMNQRTY

Common amino acids  P

Mass  95220

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  4

Net charge  0

Boman Index  1087

Hydrophobicity  94.29

Aliphatic Index  97.14

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  916.67

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 19743810

Title  Isolation and structural elucidation of euryjanicins B-D, proline-containing cycloheptapeptides from the Caribbean marine sponge Prosuberites laughlini

Doi Not available

Year  2009

Literature 2

Pubmed ID 20161148

Title  Euryjanicin A: a new cycloheptapeptide from the Caribbean marine sponge Prosuberites laughlini

Doi Not available

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18505

DRACP is developed by Dr.Zheng's team.